Catalyst Wire Dossier Catalyst Wire Dossier

Vedolizumab SC

vedolizumab · Takeda
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vedolizumab SC, covering 2025-10-06 to 2025-10-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea

See pricing